全文获取类型
收费全文 | 534篇 |
免费 | 31篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 21篇 |
妇产科学 | 14篇 |
基础医学 | 133篇 |
口腔科学 | 4篇 |
临床医学 | 35篇 |
内科学 | 103篇 |
皮肤病学 | 17篇 |
神经病学 | 33篇 |
特种医学 | 6篇 |
外科学 | 41篇 |
综合类 | 2篇 |
预防医学 | 53篇 |
眼科学 | 8篇 |
药学 | 56篇 |
肿瘤学 | 35篇 |
出版年
2020年 | 6篇 |
2019年 | 6篇 |
2018年 | 7篇 |
2016年 | 5篇 |
2015年 | 10篇 |
2014年 | 5篇 |
2013年 | 16篇 |
2012年 | 17篇 |
2011年 | 14篇 |
2010年 | 7篇 |
2009年 | 19篇 |
2008年 | 31篇 |
2007年 | 21篇 |
2006年 | 28篇 |
2005年 | 28篇 |
2004年 | 26篇 |
2003年 | 26篇 |
2002年 | 31篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1995年 | 5篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1989年 | 7篇 |
1986年 | 6篇 |
1985年 | 6篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1974年 | 4篇 |
1973年 | 6篇 |
1964年 | 4篇 |
1963年 | 7篇 |
1959年 | 6篇 |
1956年 | 5篇 |
1955年 | 4篇 |
1954年 | 5篇 |
1948年 | 4篇 |
1937年 | 5篇 |
1935年 | 8篇 |
1932年 | 5篇 |
1931年 | 4篇 |
1930年 | 4篇 |
1929年 | 5篇 |
1926年 | 5篇 |
1924年 | 4篇 |
1923年 | 5篇 |
1913年 | 4篇 |
排序方式: 共有566条查询结果,搜索用时 15 毫秒
1.
2.
Rolf W. Hartmann Martin Frotscher Dorothea Ledergerber Gerald A. Wchter Gertrud L. Grün Tom F. Sergejew 《Archiv der Pharmazie》1996,329(5):251-261
In search of potential drugs for the treatment of estrogen- and androgen-dependent cancer as well as the prophylaxis of metastases, tetralones, tetralins, and dihydronaphthalenes bearing a OCH3 substituent at the benzene nucleus and an imidazol-4-yl, imidazol-1-yl, or 1,2,4-triazol-1-yl substituent in 2-position were synthesized with and without C1-spacer between the rings (compounds 2 – 26 ). The compounds were tested in vitro for inhibition of the three target enzymes P450 arom (human placental microsomes), P450 17 (rat testicular microsomes), and P450 TxA2 (citrated human whole blood). To examine selectivity, some compounds were further tested in vitro for inhibition of P450 18 (bovine adrenal mitochondria), P450 see (bovine adrenal mitochondria) and corticoid formation (aldosterone, corticosterone; ACTH stimulated rat adrenal tissue). In vivo, selected compounds were examined in Sprague Dawley rats regarding P450 TxA2 inhibition, reduction of plasma testosterone concentration, antiuterotrophic activity (inhibition of the uterotrophic activity of androstenedione), reduction of plasma estradiol concentration (pregnant mares' serum gonadotropin-primed rats), and mammary tumor inhibiting activity (dimethylbenzanthracene-induced tumor; pre- and postmenopausal model). In the series of imidazol-4-yl compounds, which represent a novelty in the field of azole inhibitors of steroidogenic P450 enzymes, strong inhibitors of P450 arom and/or P450 17 were found: 7-OCH3-2-(imidazol-4-ylmethylene)-1-tetralone ( 4 ) and 7-OCH3-2-(imidazol-4-ylmethyl)-tetralin ( 12 ) are among the most potent inhibitors of P450 arom in vitro known so far. Compound 4 is a selective inhibitor, whereas 12 shows in addition strong inhibition of P450 17. In contrast to 12 , the 6-OCH3 derivative (compound 11 ) is a selective inhibitor of P450 17, being 50 times more potent than ketoconazole. Some imidazol-1-yl compounds show a marked inhibition of P450 TxA2: 2-(imidazol-1-ylmethyl)-1-tetralone ( 13 ) is a selective inhibitor of P450 TxA2, whereas 7-OCH3-2-(imidazol-1-ylmethyl)-tetralin ( 17 ) as well as 2-(imidazol-1-ylmethyl)-tetralin ( 16 ) and 7-OCH3-2-imidazol-1-yl-3,4-dihydronaphthalene ( 25 ) additionally show strong inhibition of P450 arom and P450 17. Regarding the other steroidogenic P450 enzymes as well as corticosterone formation, the compounds show only little inhibitory activity. Aldosterone formation, however, is inhibited at low concentrations. Nevertheless, 4 and 12 are more selective, i.e. inhibit aldosterone synthesis less than the well known inhibitor of P450 arom fadrozole. The compounds show activity in the aforementioned in vivo tests. 相似文献
3.
Gertrud Dudin Denis Alexander Fayrouz Talj Mary Deeb Salim Musallam Vazken M. Der Kaloustian 《Clinical genetics》1984,25(5):455-458
A six-months-old girl is presented with psychomotor retardation and multiple congenital malformations. The karyotype done on peripheral blood lymphocytes and skin fibroblasts was found to be 46,XX del(5)(411q13). The parents are consanguineous. Their karyotypes were normal.
The genes for Arylsulphatase B and Hexosaminidase B are not located in band 5q12. 相似文献
The genes for Arylsulphatase B and Hexosaminidase B are not located in band 5q12. 相似文献
4.
Gertrud Mueller-Eckhardt 《American journal of reproductive immunology (New York, N.Y. : 1989)》1994,32(4):281-285
PROBLEM: Due to its strong “immunomodulating” effect in several well established disorders, high-dose intravenous immunoglobulins (IVIG) has been proposed as an alternative for immunotherapy with allogeneic leucocytes in patients with unexplained recurrent spontaneous abortion. This paper is intended to provide an overview on the European experience in this field. METHOD: Five European pilot studies with a total of 172 patients as well as one controlled double-blind multicenter study including 64 patients were considered. In the latter, 5% human albumin was used as placebo. RESULTS: Success rates of the pilot studies varied from 68 to 87%. In the German controlled study, a significant specific effect of IVIG could not be verified. However, success rates for both IVIG and albumin were in the same range as for allogeneic leucocytes. CONCLUSION: At present, it is not sufficiently proven that IVIG is an appropriate tool for immunotherapy of recurrent spontaneous abortions. It is suggested that success rates of both IVIG and albumin are due to a placebo effect. However, we cannot exclude that albumin itself provides immunomodulating capacity. 相似文献
5.
Gertrud Koch Klaus Wiedemann Hansjörg Teschemacher 《Naunyn-Schmiedeberg's archives of pharmacology》1985,331(4):351-354
Summary Opioid activities of human -casomorphin-4,-5,-7 and -8 and, for comparison, of the corresponding bovine -casomorphins were studied in the guinea-pig ileum preparation. Binding parameters, i.e. K
d
-values and binding site concentrations, for the interaction of human and bovine -casomorphins with opioid receptors in rat brain homogenates were determined in inhibition experiments, using [3H]-(d-Ala2, MePhe4, Gly-ol5)enkephalin, [3H]-(d-Ala2, d-Leu5)enkephalin and [3H]ethylketazocin as -, - and -opioid receptor ligands. Analysis of binding data was performed using a non-linear curve fitting program. All -casomorphins examined displayed opioid activity. The affinity was highest for -receptors, less so for -receptors and lowest for -receptors. It is suggested that human -casomorphins might play a role as food hormones. 相似文献
6.
Hartmut Heine Gertrud Schaeg Theodor Nasemann 《Archives of dermatological research》1978,263(1):83-90
Zusammenfassung Bei Virusacanthomen können in den ballonierten Zellen des Stratum spinosum und granulosum alle Übergänge von multivesiculären Körpern (MVK) zu Keratinosomen beobachtet werden. Eine Besonderheit stellen die Rad-Körper bei Condylomata acuminata dar. Diese Gebilde sind als typisch für nicht verhornende Plattenepithelien beschrieben worden. Eine Beteiligung intercellulär ausgeschleuster Rad-Körper, MVK und atypischer Keratinosomen an einer nicht regelhaften basoapikalen Diffusionsbarriere in der Epidermis bei Virusacanthomen wird diskutiert. Auf Grund der Beziehungen von MVK zum Golgi-Apparat, ihrer Umwandlung zu teilweise atypischen Keratinosomen bei Virssacanthomen und Ausschleusung in den Intercellularraum könnte dafür sprechen, daß die enzymatisch gesteuerte Rückkopplung zwischen Zelloberfläche und Synthesefähigkeit der Keratinocyten virusbedingt verändert ist. Die Störung scheint sich am Golgi-Apparat zu manifestieren und durch das Terrain spezifiziert zu werden.Mit Unterstützung durch die Deutsche Forschungsgemeinschaft 相似文献
7.
C. Mueller-Eckhardt W. Kayser Christa Frster Gertrud Mueller-Eckhardt C. Ringenberg 《Vox sanguinis》1982,43(2):76-81
A technique is described which permits the detection of platelet-specific, noncomplement-fixing ("blocking') PlA1 antibodies in serologically negative sera of mothers from children suffering from neonatal alloimmune thrombocytopenia. The technique consists of (1) antibody enrichment in eluates prepared from maternal serum and PlA1-positive platelets, and (2) quantitation of antibodies in eluates by the platelet radioactive anti-IgG test. With this assay, PlA1 antibodies were demonstrated in 6 out of 7 maternal sera, and anti-A antibodies in one. It proved valuable also for longitudinal studies for periods up to 30 months after delivery. 相似文献
8.
d,l-Camphor was detected as a new inducer of hydroxylase in the liver musomes of female mice. After a 2-day inhalation of d,l-camphor, cyt. P-450 and the ethylumbelliferone dealkylase were increased by 250 per cent and the NADPH-cyt. P-450 reductase by 350 per cent. The product [NADPH-cyt. P-450 reductase activity × cyt. P450 concentration] was shown to be a suitable reference parameter for the ethylumbelliferone dealkylase activity in the liver musomes during the treatment with four different inducers. The relative dealkylase activity Q was much decreased during inhalation of cyclohexane or d,l-camphor.Obviously these two inducers preferably enhanced cyt. P-450 species with a low dealkylase activity. The Q-values were reproducible. Q was increased by 100 per cent during induction of a MC-sensitive mouse strain with 3-methylcholanthrene, but it was only moderately decreased by induction with phenobarbital. Corresponding to this, methylcholanthrene is known to selectively induce a cyt. P-448 with high dealkylase activity whereas phenobarbital is known to change the hydroxylase specificity in the liver musomes not very much. 相似文献
9.
Gertrud Berg Erik Blomquist Eva Cavallin-st hl 《Acta oncologica (Stockholm, Sweden)》2003,42(5):582-588
A systematic review of radiation therapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for evaluation of the scientific literature are described separately (Acta Oncol 2003; 42: 357-365). This synthesis of the literature on radiation therapy for brain tumours is based on data from 9 randomized trials and 1 meta-analysis. Moreover, data from 2 prospective studies, 3 retrospective studies and 4 other articles were used. In total, 19 scientific articles are included, involving 4 266 patients. The results were compared with those of a similar overview from 1996 including 11 252 patients. The conclusions reached can be summarized as follows: The conclusion from SBU 129/2 that curative treatment is not available for patients with high-grade malignant glioma (grade III and IV) is still valid.The survival benefit from postoperative radiotherapy compared to supportive care only or chemotherapy is about 3-4 months, as demonstrated in earlier randomized studies.
Quality of life is now currently estimated and considered to be of major importance when reporting the outcome of treatment for patients with brain tumours.
There is no scientific evidence that radiotherapy using hyper- and hypofractionation leads to longer survival for patients with high-grade malignant glioma than conventional radiotherapy. There is large documentation, but only one randomized study.There is some documentation to support the view that patients with grade IV glioma and poor prognosis can be treated with hypofractionation and with an outcome similar to that after conventional fractionation. A shorter treatment time should be convenient for the patient.Documentation of the benefit of a radiotherapy boost with brachytherapy is limited and no conclusion can be drawn.There is no scientific evidence that radiotherapy prolongs life for patients with low-grade glioma.There are some data supporting that radiotherapy can be used to treat symptoms in patients with low-grade glioma. As no controlled studies have been reported, no firm conclusion can be drawn. 相似文献
Quality of life is now currently estimated and considered to be of major importance when reporting the outcome of treatment for patients with brain tumours.
There is no scientific evidence that radiotherapy using hyper- and hypofractionation leads to longer survival for patients with high-grade malignant glioma than conventional radiotherapy. There is large documentation, but only one randomized study.There is some documentation to support the view that patients with grade IV glioma and poor prognosis can be treated with hypofractionation and with an outcome similar to that after conventional fractionation. A shorter treatment time should be convenient for the patient.Documentation of the benefit of a radiotherapy boost with brachytherapy is limited and no conclusion can be drawn.There is no scientific evidence that radiotherapy prolongs life for patients with low-grade glioma.There are some data supporting that radiotherapy can be used to treat symptoms in patients with low-grade glioma. As no controlled studies have been reported, no firm conclusion can be drawn. 相似文献
10.